Change search
ReferencesLink to record
Permanent link

Direct link
Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program
Show others and affiliations
2008 (English)In: Diabetes, ISSN 0012-1797, E-ISSN 1939-327X, Vol. 57, no 9, 2503-2510 p.Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: Genome-wide association scans (GWASs) have identified novel diabetes-associated genes. We evaluated how these variants impact diabetes incidence, quantitative glycemic traits, and response to preventive interventions in 3,548 subjects at high risk of type 2 diabetes enrolled in the Diabetes Prevention Program (DPP), which examined the effects of lifestyle intervention, metformin, and troglitazone versus placebo.

RESEARCH DESIGN AND METHODS: We genotyped selected single nucleotide polymorphisms (SNPs) in or near diabetes-associated loci, including EXT2, CDKAL1, CDKN2A/B, IGF2BP2, HHEX, LOC387761, and SLC30A8 in DPP participants and performed Cox regression analyses using genotype, intervention, and their interactions as predictors of diabetes incidence. We evaluated their effect on insulin resistance and secretion at 1 year.

RESULTS: None of the selected SNPs were associated with increased diabetes incidence in this population. After adjustments for ethnicity, baseline insulin secretion was lower in subjects with the risk genotype at HHEX rs1111875 (P = 0.01); there were no significant differences in baseline insulin sensitivity. Both at baseline and at 1 year, subjects with the risk genotype at LOC387761 had paradoxically increased insulin secretion; adjustment for self-reported ethnicity abolished these differences. In ethnicity-adjusted analyses, we noted a nominal differential improvement in beta-cell function for carriers of the protective genotype at CDKN2A/B after 1 year of troglitazone treatment (P = 0.01) and possibly lifestyle modification (P = 0.05).

CONCLUSIONS: We were unable to replicate the GWAS findings regarding diabetes risk in the DPP. We did observe genotype associations with differences in baseline insulin secretion at the HHEX locus and a possible pharmacogenetic interaction at CDKNA2/B.

Place, publisher, year, edition, pages
Alexandria: American diabetes association , 2008. Vol. 57, no 9, 2503-2510 p.
Keyword [en]
beta-cell function, insulin resistance, glucose tolerance, variants, susceptibility, loci, polymorphisms, secretion, CDKAL1, genes
National Category
Endocrinology and Diabetes
URN: urn:nbn:se:umu:diva-19086DOI: 10.2337/db08-0284ISI: 000258869000029PubMedID: 18544707OAI: diva2:201331
Available from: 2009-03-04 Created: 2009-03-04 Last updated: 2016-08-17Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Franks, Paul W
By organisation
In the same journal
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 21 hits
ReferencesLink to record
Permanent link

Direct link